Defence Announces Extension of Private Placement, Continues Development of Its Radiopharmaceuticals and ADC Programs

          Defence Announces Extension of Private Placement, Continues Development of Its Radiopharmaceuticals and ADC ProgramsNovember 04, 2024 6:15 PM EST | Source: Defence Therapeutics Inc.Vancouver, British Columbia--(Newsfile Corp. - November 4, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing radiopharmaceuticals and ADC products using its proprietary platform and drug delivery technologies in additi ...